pubmed.ncbi.nlm.nih.gov

Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus - PubMed

️Wed Jan 01 1997

Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus

D H Kedes et al. J Clin Invest. 1997.

Abstract

Over 85% of patients with Kaposi's sarcoma (KS) are seropositive for antibodies to the latency-associated nuclear antigen (LANA) expressed in B cell lines infected with Kaposi's sarcoma-associated herpesvirus (KSHV). The presence of antibodies to LANA strongly correlates with the risk of developing the disease. However, the identity of the protein(s) comprising LANA and the corresponding gene(s) has remained unclear. To identify potential latent gene candidates for LANA, we probed total RNA extracted from BCBL-1 cells (a B cell line latently infected with KSHV) using lambda clones that span the KSHV genome. One region encoding latent transcripts spanned KSHV open reading frames (orfs) 71 (K13), 72 (v-cyclin), and 73. Among these, however, only orf 73, when expressed in heterologous mammalian cell systems, reacted with KSHV antibody-positive human sera, resulting in a punctate nuclear staining pattern reminiscent of LANA in BCBL-1 cells. Furthermore, extracts from cells expressing the orf 73 protein product specifically blocked the binding of KS patient antibodies to LANA. Finally, seroreactivity with recombinant orf 73 protein exactly paralleled reactivity with classical LANA as expressed in BCBL-1 cells, both in KS patients and in other groups. Together, these data support the identification of KSHV orf 73 as the gene encoding the dominant immunogenic component of LANA.

PubMed Disclaimer

Cited by

Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA.
Lu F, Tsai K, Chen HS, Wikramasinghe P, Davuluri RV, Showe L, Domsic J, Marmorstein R, Lieberman PM. Lu F, et al. J Virol. 2012 May;86(10):5752-62. doi: 10.1128/JVI.07216-11. Epub 2012 Mar 14. J Virol. 2012. PMID: 22419807 Free PMC article.
Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
Lan K, Kuppers DA, Verma SC, Sharma N, Murakami M, Robertson ES. Lan K, et al. J Virol. 2005 Jun;79(12):7453-65. doi: 10.1128/JVI.79.12.7453-7465.2005. J Virol. 2005. PMID: 15919901 Free PMC article.
Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest.
Ottinger M, Christalla T, Nathan K, Brinkmann MM, Viejo-Borbolla A, Schulz TF. Ottinger M, et al. J Virol. 2006 Nov;80(21):10772-86. doi: 10.1128/JVI.00804-06. Epub 2006 Aug 23. J Virol. 2006. PMID: 16928766 Free PMC article.

References

1. Lancet. 1996 Sep 28;348(9031):858-61 - PubMed
1. Annu Rev Genet. 1995;29:651-74 - PubMed
1. Lancet. 1996 Oct 26;348(9035):1133-8 - PubMed
1. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14862-7 - PubMed
1. JAMA. 1997 Feb 12;277(6):478-81 - PubMed

Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus - PubMed